CRNX
Crinetics Pharmaceuticals Inc

1,101
Loading...
Loading...
Crinetics Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its product candidate, CRN00808, is an oral nonpeptide somatostatin agonist for the treatment of acromegaly. The firm is also developing other oral nonpeptide somatostatin agonists for neuroendocrine tumors and hyperinsulinism, as well as an oral nonpeptide ACTH antagonist for the treatment of Cushing's disease. The company was founded by R. Scott Struthers, Yun-Fei Zhu and Stephen F. Betz in 2008 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
437

Frequently Asked Questions

What is Market Cap of Crinetics Pharmaceuticals Inc?
What is the 52-week high for Crinetics Pharmaceuticals Inc?
What is the 52-week low for Crinetics Pharmaceuticals Inc?
What is Crinetics Pharmaceuticals Inc stock price today?
What was Crinetics Pharmaceuticals Inc stock price yesterday?
What is the PE ratio of Crinetics Pharmaceuticals Inc?
What is the Price-to-Book ratio of Crinetics Pharmaceuticals Inc?
What is the 50-day moving average of Crinetics Pharmaceuticals Inc?
How many employess does Crinetics Pharmaceuticals Inc has?

Latest CRNX News

View

Advertisement. Remove ads.

Advertisement. Remove ads.